Revised BPH
Revised BPH
As a person age the natural process of wear and tear will occur to a human body.
What usually happens is, due to limited information on this field they do not know that a
simple pain could indicate a serious problem. Benign Prostatic Hyperplasia is a
common problem among older men that negatively impacts the quality of life and results
in considerable medical intervention and expense.
The term Benign Prostatic Hyperplasia (BPH) describes a proliferative process of
the cellular elements of the prostate, or the voiding dysfunction resulting from prostatic
enlargement and bladder outlet obstruction where there is an increased in the total
number of stromal and glandular epithelial cells within the transition zone of the prostate
gland. This hyperplasia causes formation of large, discrete prostatic nodules (Shapiro et
al, 1992).
BPH are classified accordingly by Stages: Stage I, means no significant
obstruction, and no bothersome symptoms; Stage II is where symptoms are
bothersome with significant obstruction. In Stage III, there would be significant
obstruction and irrespective symptoms and lastly, Stage IV has positive complications of
BPH such as retention of urine, recurrent gross hematuria, urinary infection and bladder
stones formation (Foot KT, 1995).
According to histologic evidence of prostate enlargement begins about the third
decade of life and increases proportionally with aging. As many as, 14 million in the
Asian country have BPH. Worldwide, approximately 30 million men have symptoms
related to BPH (Wei JT, 2005). Specifically, about 43% of men in their 40s will have
evidence of BPH, as will 50% of men in their 50s, 75% to 88% in their 80s, and nearly
100% of men reaching the ninth decade of life. Some evidence has reported a higher
incidence of benign prostatic hyperplasia particularly fast-growing BPH in men with
obesity, heart and circulatory diseases, and type 2 diabetes. Diabetes and
hypertension, in any case, worsens urinary tract symptoms in men with BPH due to the
compelling indication for the use of an alpha blocker in the treatment of hypertension
and physician-diagnosed diabetes, increased serum insulin and elevated fasting plasma
glucose have been associated with increased prostate size and increased risk of
prostate enlargement. In one study, flow rates were adversely affected by diabetes,
although residual urine volumes were not significantly greater. (Egan KB, 2016)
Patient George, 79-year-old male who was admitted at Adventist Medical Center,
who was diagnosed with Benign Prostatic Hyperplasia (BPH), was chosen for this case
study for us to further understand his case/condition and to help him for his treatment
regimen to prevent future problems in regards to health, environment, lifestyle or
behavior.
This case study would also focused in helping the patient to understand and
determine the causative factors of the disease in the human body, also to provide
prompt intervention and formulate solutions to the said problems. Thorough
assessments findings that were gathered will be used for basis for planning of nursing
care and identify other relevant problems with current health. Furthermore, this case
study also opted to identify specific theoretical causes and clinical manifestations to the
involved disease entity and to determine the patient’s level of awareness about
diseases that involves the cardiovascular system.
Furthermore, this case study also wanted to identify nursing interventions and
minimized clinical symptoms and evaluate the patients level of awareness regarding the
disease prevention and diagnosis.